Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2375 of 3173 entries
View as:

A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06003829 Org: User:
Start: 07/31/23 End: 09/20/23 Due: 09/20/24

Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides

Phase: N/A Priority: Normal
NCT ID: NCT04459767 Org: User:
Start: 08/06/20 End: 12/15/20 Due: 12/15/21

IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03981900 Org: User:
Start: 01/04/19 End: 02/06/23 Due: 02/06/24

The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02393807 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03395184 Org: User:
Start: 02/02/18 End: 10/19/23 Due: 10/19/24

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05050682 Org: User:
Start: 10/07/21 End: 12/10/21 Due: 12/10/22

Zithromax EV in Community-Acquired Pneumonia (CAP)

Phase: N/A Priority: Normal
NCT ID: NCT00137007 Org: User:
Start: 11/30/03 End: 09/30/05 Due: 09/30/06

Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01185184 Org: User:
Start: 08/31/10 End: 08/31/10 Due: 08/31/11

A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00308464 Org: User:
Start: 07/31/06 End: 12/31/07 Due: 12/31/08

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03570047 Org: User:
Start: 05/08/18 End: 10/31/18 Due: 10/31/19

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00043394 Org: User:
Start: 09/30/02 End: 10/31/03 Due: 10/31/04

A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses

Phase: N/A Priority: Normal
NCT ID: NCT01244620 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00463918 Org: User:
Start: 05/31/07 End: 12/31/07 Due: 12/31/08

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04345367 Org: User:
Start: 06/11/20 End: 07/13/21 Due: 07/13/22

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

Phase: N/A Priority: Normal
NCT ID: NCT01578850 Org: User:
Start: 07/31/12 End: 03/31/15 Due: 03/31/16

A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males

Phase: N/A Priority: Normal
NCT ID: NCT03792477 Org: User:
Start: 01/19/19 End: 04/02/20 Due: 04/02/21

A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults

Phase: N/A Priority: Normal
NCT ID: NCT05831124 Org: User:
Start: 04/19/23 End: 06/26/24 Due: 06/26/25

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06237049 Org: User:
Start: 01/31/24 End: 09/13/24 Due: 09/13/25

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161850 Org: User:
Start: 02/28/02 End: 08/31/02 Due: 08/31/03

Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa

Phase: N/A Priority: Normal
NCT ID: NCT01103713 Org: User:
Start: 03/31/11 End: 10/31/13 Due: 10/31/14

Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-

Phase: N/A Priority: Normal
NCT ID: NCT03014206 Org: User:
Start: 06/15/15 End: 01/31/17 Due: 01/31/18

Chemoprevention of Oral Premalignant Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00036283 Org: User:
Start: 11/30/00 End: 04/30/04 Due: 04/30/05

Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

Phase: N/A Priority: Normal
NCT ID: NCT01017926 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Phase: N/A Priority: Normal
NCT ID: NCT04452838 Org: User:
Start: 06/26/20 End: 01/04/21 Due: 01/04/22

A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT05224609 Org: User:
Start: 04/28/22 End: 08/13/24 Due: 08/13/25